Press Releases Aclarion, Inc.

Equities

ACON

US6551872012

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-03 EDT			5-day change	1st Jan Change
0.315 ^USD	+5.00%		+0.80%	-90.16%

05-26	Certain Warrants of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	CI
05-26	Certain Stock Options of Aclarion, Inc. are subject to a Lock-Up Agreement Ending on 26-MAY-2024.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain	04-25	AQ
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs	03-04	AQ
Aclarion Announces Closing of $3.0 Million Public Offering	02-27	AQ
Aclarion Announces Pricing of $3.0 Million Public Offering	02-26	AQ
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership	02-05	AQ
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD	01-22	AQ
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution	01-17	AQ
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan	01-08	AQ
Aclarion Announces Reverse Stock Split	01-02	AQ
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams	11-27	AQ
Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption	11-08	AQ
Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD	11-06	AQ
Aclarion Presents at the NIH HEAL Initiative Fall Meeting	11-01	AQ
Nano-Cap News Catalyst Watchlist (SING, NVVE, ACON, FFIE)	23-10-26	AQ
Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver	23-10-25	AQ
Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting	23-10-24	AQ
Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan	23-10-23	AQ
Aclarion Provides Updated Investor Presentation and Corporate Update	23-10-02	AQ
Better Data Better Care OCTOBER 2023 NASDAQ: ACON - Form 8-K	23-09-28	PU
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report	23-08-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aclarion, Inc.

Equities

ACON

US6551872012

Press Releases

Filters